News

Marina Biotech announced that it has changed its name to Adhera Therapeutics and that it will begin using the ticker ATRX, in each case effective October 9, 2018. This new name reflects…
Read More...

Recipharm has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros…
Read More...

USP is announcing a new program to assist manufacturers in their drug development efforts—Impurities for Development (IfD). This new program can help pharmaceutical manufacturers meet…
Read More...

Noramco, a leader in controlled substances and cannabinoids, is adding commercial-scale capacity of dronabinol (THC) at its Athens, Georgia, United States facility. The expansion comes…
Read More...

Neurocrine Biosciences and Jnana Therapeutics announced that they have entered into a research collaboration aimed at discovering novel small molecule therapeutics for multiple targets…
Read More...

Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell therapy manufacturing process for chimeric antigen receptor…
Read More...

Wave Life Sciences Ltd. announced plans to design and advance stereopure oligonucleotide therapeutics for the potential treatment of rare, inherited eye diseases. Wave’s research in…
Read More...

Novartis announced that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's New Drug Application (NDA) and Marketing…
Read More...

Sarepta Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Paragon Bioservices (Paragon), which will provide Sarepta access to…
Read More...

Novan announced that the Company has expanded its partnership with Sato Pharmaceutical, a Japanese company with a prescription pharmaceutical business specializing in dermatology, to…
Read More...

Amicus Therapeutics announced a major collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania (Penn) to pursue research and…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in…
Read More...

Boehringer Ingelheim and Eli Lilly and Company presented the full results of the long-term cardiovascular outcome trial, CARMELINA, which studied the impact of Trajenta (linagliptin) on…
Read More...

Evonik announced the launch of an advanced combination polymer for enteric coatings. EUDRAGIT® FL 30 D-55 leverages Evonik’s new, proprietary AEMP® technology (Advanced Excipient…
Read More...

Kite, a Gilead Company and HiFiBiO Therapeutics, a biotechnology company focused on the discovery of therapeutic antibodies through single B cell screening and analysis, announced the…
Read More...

Daiichi Sankyo Company announced that axicabtagene ciloleucel (formerly KTE-C19) has been granted Orphan Drug designation by the Japan Ministry of Health, Labour and Welfare (MHLW) for…
Read More...

Chugai Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by…
Read More...

Alnylam Pharmaceuticals announced updated positive results from its Phase 1/2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting…
Read More...

Prana Biotechnology announced further pre-clinical evidence for PBT434 will be presented in a poster at the International Congress of Parkinson’s Disease and Movement Disorders in Hong…
Read More...

Evotec AG announced that it has established an initiative with Sanofi through the launch of a newly created BRIDGE, called LAB031, designed to accelerate drug discovery across multiple…
Read More...